Long-term HAE Prophylaxis with Berotralstat Is Well Tolerated and Effective: Analysis for the APeX-S Study

ALLERGOLOGIE(2023)

Cited 0|Views4
No score
Abstract
Berotralstat is a first-line once-daily oral prophylaxis for hereditary angioedema (HAE). We report the final long-term safety and effectiveness of berotralstat over 96 weeks for patients enrolled in APeX-S.
More
Translated text
Key words
berotralstat,prophylaxis,long-term
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined